Logo image of CHR

CHEER HOLDING INC-A (CHR) Stock Fundamental Analysis

NASDAQ:CHR - Nasdaq - KYG399732042 - Common Stock - Currency: USD

1.21  +0.04 (+3.86%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CHR. CHR was compared to 70 industry peers in the Interactive Media & Services industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
Each year in the past 5 years CHR has been profitable.
CHR had a positive operating cash flow in each of the past 5 years.
CHR Yearly Net Income VS EBIT VS OCF VS FCFCHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

CHR has a Return On Assets of 7.49%. This is amongst the best in the industry. CHR outperforms 85.71% of its industry peers.
CHR's Return On Equity of 8.51% is amongst the best of the industry. CHR outperforms 81.43% of its industry peers.
The Return On Invested Capital of CHR (6.59%) is better than 78.57% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 11.47%.
Industry RankSector Rank
ROA 7.49%
ROE 8.51%
ROIC 6.59%
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
CHR Yearly ROA, ROE, ROICCHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 17.64%, CHR belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of CHR has declined.
With an excellent Operating Margin value of 17.39%, CHR belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR has declined.
The Gross Margin of CHR (73.24%) is better than 64.29% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 17.39%
PM (TTM) 17.64%
GM 73.24%
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
CHR Yearly Profit, Operating, Gross MarginsCHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHR is still creating some value.
The number of shares outstanding for CHR has been increased compared to 1 year ago.
Compared to 5 years ago, CHR has less shares outstanding
Compared to 1 year ago, CHR has a worse debt to assets ratio.
CHR Yearly Shares OutstandingCHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CHR Yearly Total Debt VS Total AssetsCHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CHR has an Altman-Z score of 2.63. This is not the best score and indicates that CHR is in the grey zone with still only limited risk for bankruptcy at the moment.
CHR has a better Altman-Z score (2.63) than 72.86% of its industry peers.
CHR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CHR has a better Debt to Equity ratio (0.00) than 67.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.63
ROIC/WACC0.94
WACC7.05%
CHR Yearly LT Debt VS Equity VS FCFCHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 7.66 indicates that CHR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.66, CHR belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
A Quick Ratio of 7.66 indicates that CHR has no problem at all paying its short term obligations.
CHR's Quick ratio of 7.66 is amongst the best of the industry. CHR outperforms 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 7.66
Quick Ratio 7.66
CHR Yearly Current Assets VS Current LiabilitesCHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

3. Growth

3.1 Past

CHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.97%.
The Earnings Per Share has been growing by 90.58% on average over the past years. This is a very strong growth
CHR shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
CHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.28% yearly.
EPS 1Y (TTM)-25.97%
EPS 3Y-22.48%
EPS 5Y90.58%
EPS Q2Q%-42.52%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-10.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHR Yearly Revenue VS EstimatesCHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 50M 100M 150M

3

4. Valuation

4.1 Price/Earnings Ratio

CHR is valuated cheaply with a Price/Earnings ratio of 0.48.
Based on the Price/Earnings ratio, CHR is valued cheaper than 98.57% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.85. CHR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.48
Fwd PE N/A
CHR Price Earnings VS Forward Price EarningsCHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.89
CHR Per share dataCHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The decent profitability rating of CHR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHEER HOLDING INC-A

NASDAQ:CHR (5/1/2025, 8:51:55 PM)

1.21

+0.04 (+3.86%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)03-10 2025-03-10
Earnings (Next)N/A N/A
Inst Owners17.17%
Inst Owner ChangeN/A
Ins Owners0.74%
Ins Owner ChangeN/A
Market Cap14.08M
Analysts80
Price TargetN/A
Short Float %0.28%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.48
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF 0.62
P/B 0.05
P/tB 0.05
EV/EBITDA -5.89
EPS(TTM)2.51
EY207.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)1.97
OCFY162.41%
SpS12.65
BVpS26.2
TBVpS22.72
PEG (NY)N/A
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 8.51%
ROCE 8.34%
ROIC 6.59%
ROICexc 18.54%
ROICexgc 29.52%
OM 17.39%
PM (TTM) 17.64%
GM 73.24%
FCFM N/A
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
ROICexc(3y)21.89%
ROICexc(5y)25.49%
ROICexgc(3y)29.91%
ROICexgc(5y)33.2%
ROCE(3y)11.4%
ROCE(5y)17.04%
ROICexcg growth 3Y-11.82%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.62%
ROICexc growth 5YN/A
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.05
Cap/Depr 650.5%
Cap/Sales 16.89%
Interest Coverage 78.74
Cash Conversion 77.77%
Profit Quality N/A
Current Ratio 7.66
Quick Ratio 7.66
Altman-Z 2.63
F-Score4
WACC7.05%
ROIC/WACC0.94
Cap/Depr(3y)296.64%
Cap/Depr(5y)223.79%
Cap/Sales(3y)7.33%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.97%
EPS 3Y-22.48%
EPS 5Y90.58%
EPS Q2Q%-42.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-10.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.6%
EBIT growth 3Y-10.99%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-104.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.76%
OCF growth 3Y-21.03%
OCF growth 5YN/A